- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefTM
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request A Presentation
- ADPKD Simulator
- Patient Resources
- Log In
- Join
- Log Out
- Account
Archives
Advances & Future Goals For Kidney Care
Over a year ago, President Donald Trump signed an executive order that has led to the most aggressive push to improve the lives of patients with kidney disease since Congress agreed to pay for life-saving dialysis treatment in 1972. This webinar will explore the progress on that directive and discuss the goals, key regulatory measures, and challenges it may impose on the renal community. Additionally, the executive order has accelerated innovation in nephrology in a way that has never been seen before. In the end will it improve patient outcomes? Join the NephU Community for an informative session and a live Q & A with Mark Neumann.
*Speaker is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). The moderator is an employee of OPDC.
If you would like to register for the 3:00 pm to 4:00 pm EST broadcast, please click below:
Featured Speaker
Mark Neumann
-
Healthcare Writer & Editor*
Mark Neumann started his career as a healthcare writer and editor in 1984 and has been covering clinical, regulatory, and economic issues in the kidney care field for the past 30 years. He is a previous winner of the President’s Award from the National Association of Nephrology Technicians and Technologists and a Medal of Excellence Award winner from the American Association of Kidney Patients.
Moderator
Leah Beaird, MS, RD, FNKF
Nephrology Medical Science Liaison-
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Leah Beaird MS, RD, FNKF, is a renal dietitian and Medical Science Liaison at Otsuka Pharmaceutical. Her expertise is autosomal polycystic kidney disease, mineral bone disorders and renal nutrition. Prior to working in industry, Ms. Beaird was a clinician for both CKD and dialysis patients. She is active with the National Kidney Foundation and chair of the Arizona council on renal nutrition. Leah earned her MS in nutrition from Arizona State University.
Location
Online via NephU.org
Related Events
-
Kidney Healthy Cooking Series Featuring Celebrity Chef JJ: Episode 3
June 6 from 12:00 pm to 1:00 pm -
Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
June 15 from 12:00 pm to 1:00 pm
Event Navigation
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2023 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.